60–70 % of IFN-γ−/−
NOD.H-2h4 mice given NaI-supplemented water develop a slow onset autoimmune
thyroid disease, characterized by thyrocyte epithelial cell hyperplasia/
proliferation (TEC H/P). TEC H/P develops much earlier in
CD28−/− mice and nearly 100 % (both
sexes) have severe TEC H/P at 4 months of age. Without NaI supplementation,
50% of 5–6 month old
CD28−/−IfFN-γ−/−
mice develop severe TEC H/P, and 2–3 weeks of NaI is sufficient for
optimal development of severe TEC H/P. Mice with severe TEC H/P are hypothyroid
and normalization of serum thyroxine (T4) levels does not reduce TEC H/P.
Activated CD4+ T cells are sufficient to transfer TEC H/P to SCID
recipients. Thyroids of mice with TEC H/P have infiltrating T cells and expanded
numbers of proliferating thyrocytes that highly express CD40. CD40 facilitates,
but is not required for development of severe TEC H/P, as
CD40−/−IFN-γ−/−CD28−/−
mice develop severe TEC H/P. Accelerated development of TEC H/P in
IFN-γ−/−
CD28−/− mice is a result of reduced Treg numbers
as CD28−/− mice have significantly fewer Tregs, and
transfer of CD28-positive Tregs inhibits TEC H/P. Essentially all female
IFN-γ−/−
CD28−/−NOD.H-2h4 mice have substantial
lymphocytic infiltration of salivary glands and reduced salivary flow by 6
months of age, thereby providing an excellent new model of autoimmune
exocrinopathy of the salivary gland. This is one of very few models where
autoimmune thyroid disease and hypothyroidism develop in most mice by 4 months
of age. This model will be useful for studying the effects of hypothyroidism on
multiple organ systems.